@IanARowe @NASH_and_coffee @rrosenblattmd @AlinaAllenMD @SonalKumarMD @ebtapper @JHepatology 1.Great points re liver fibrosis tests in community.Agree with all points.Evolving https://t.co/1gbuerb9Yp single perfect strategy but huge improvement on previous
RT @ucl_discovery: Open Access UCL Research: Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic f…
@drobeirne @wrosenberg7
RT @ucl_discovery: Open Access UCL Research: Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic f…
RT @drobeirne: Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver disease. More evide…
Open Access UCL Research: Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver disease https://t.co/crUab5f1o7
RT @drobeirne: Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver disease. More evide…
RT @drobeirne: Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver disease. More evide…
@nselvapatt @IHepatology @AlchepUK